Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents. 2014

Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
Key Lab of New Drug Design and Discovery of Liaoning Province, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, 110016 Shenyang, PR China.

A series of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds were designed, synthesized and evaluated for their anticancer activity. Most compounds displayed good to excellent potency against four tested cancer cell lines as compared with GDC-0941 and sorafenib. In this study, a promising compound 36 (PI3Kα IC50 = 0.027 μM) was identified, which showed the most potent antitumor activities with IC50 values of 0.057 μM, 0.039 μM, 0.25 μM, and 0.23 μM against H460, HT-29, MKN-45 and MDA-MB-231 cell lines, respectively. In addition, the SAR analyses indicated that compounds with 4-morpholino group at the C-4 position of thieno[3,2-d]pyrimidine moiety exhibited superior activities than compounds bearing chain amino groups. In addition, compounds with mono-methoxy group at the 3-position or dimethyl groups at the 3,5-position on the terminal phenyl ring were more active. The SAR analyses will guide us to further refine the structure of the thieno[3,2-d]pyrimidine derivatives to achieve optimum anticancer activity.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012664 Semicarbazones A class of organic compounds that are derivatives of imines formed by condensation reactions between KETONES or ALDEHYDES and SEMICARBAZIDES. Semicarbazone
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
October 2014, European journal of medicinal chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
September 2019, Bioorganic chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
May 2024, Bioorganic chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
June 2020, Bioorganic chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
February 2020, European journal of medicinal chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
September 2017, Acta pharmaceutica (Zagreb, Croatia),
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
January 2019, Bioorganic & medicinal chemistry letters,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
September 2017, European journal of medicinal chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
July 2023, Bioorganic chemistry,
Zijian Liu, and Shasha Wu, and Yu Wang, and Ruijuan Li, and Jian Wang, and Lihui Wang, and Yanfang Zhao, and Ping Gong
December 2019, Chemical biology & drug design,
Copied contents to your clipboard!